Feed Item (AI Text)
Title: BioClonetics Antibody Effectively Neutralizes 95% of HIV Isolates | BioClonetics Immunotherapeutics
Canonical URL: https://wefunder.com/feed/92108
Published at: 2018-07-05 17:45:13 UTC
Updated at: 2025-07-17 19:12:37 UTC

Content summary:
This update was originally written by BioClonetics CEO/President Charles Cotropia BioClonetics is validating its anti-HIV monoclonal antibody technology having now produced quantity and quality sufficient recombinant antibodies for neutr...

Key claims:
- Title: BioClonetics Antibody Effectively Neutralizes 95% of HIV Isolates | BioClonetics Immunotherapeutics | citation: https://wefunder.com/feed/92108#claim-feed-item-title
- Published at: 2018-07-05 17:45:13 UTC | citation: https://wefunder.com/feed/92108#claim-feed-item-published-at

Author: Katie Kobetsky
Subject: BioClonetics Immunotherapeutics
Entity ID: wefunder:feed_item:92108